CIK 0001709941
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
BioAge Labs, Inc.
Sign in to watch- Ticker
- BIOA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474721157
- Phone
- +1 510-806-1445
- Business address
- 5885 HOLLIS STREET, SUITE 370, EMERYVILLE, CA, 94608
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-17 | Morgen Eric Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +110,000 | 110,000 | ||
| 2026-02-17 | Morgen Eric Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2025-02-18 | Morgen Eric Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2025-02-18 | Morgen Eric Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2024-09-25 | Morgen Eric Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +4,952 | 4,952 | ||
| 2024-04-17 | Morgen Eric Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +257,973 | 257,973 | ||
| 2024-04-17 | Morgen Eric Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +13,598 | 13,598 |
Page 1 of 1 · 7 trades